Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2012
10/23/2012US8293482 Fibronectin type III domain based scaffold compositions, methods and uses
10/23/2012US8293240 Method of treating drug-resistant cancer
10/23/2012US8293239 Methods of treating chronic pain
10/23/2012US8293238 GDF3 antibodies and related methods
10/23/2012US8293237 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
10/23/2012US8293235 Humanization of rabbit antibodies using a universal antibody framework
10/23/2012US8293234 Antibodies which bind and inhibit blood factor VIII
10/23/2012US8293233 Method for isolation of soluble polypeptides
10/23/2012CA2628354C Organic cation transporter genes
10/23/2012CA2621590C Detection and measurement of blood-feeding activity
10/23/2012CA2522379C The severe acute respiratory syndrome coronavirus
10/23/2012CA2488127C Antibodies directed against prothrombin fragment f1+2, the preparation and use thereof
10/23/2012CA2418802C Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
10/23/2012CA2418411C Inhibitory, monoclonal antibody against blood clotting factor vii-activating protease
10/23/2012CA2412494C Agonist anti-trk-c monoclonal antibodies
10/23/2012CA2386141C A novel polypeptide and gene encoding the same
10/23/2012CA2384978C Udp-n-acetylglucosamine: galactose-.beta.1,3-n-acetylgalactosamine-.alpha.-r/(glcnac to galnac) .beta.1,6-n-acetylglucosaminyltransferase, c2gnt3
10/23/2012CA2359840C Glycosylated leptin compositions and related methods
10/23/2012CA2315282C Single-chain polypeptides comprising troponin i and troponin c
10/23/2012CA2284829C Immunotherapy of b-cell malignancies using anti-cd22 antibodies
10/23/2012CA2257839C Gamma-heregulin
10/18/2012WO2012142411A1 Systems and methods for detecting hent1 expression in hematological disorders
10/18/2012WO2012142391A1 Anti- il-1r1 inhibitors for use in cancer
10/18/2012WO2012142286A1 Methods for suppressing allergic reactions
10/18/2012WO2012142164A1 Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
10/18/2012WO2012141798A1 Adam6 mice
10/18/2012WO2012141791A1 Polyclonal antibody compositions
10/18/2012WO2012141737A1 Compositions, antibodies, asthma diagnosis methods, and methods for preparing antibodies
10/18/2012WO2012141554A2 Complex in which an anti-cotinine antibody is bound to a binder material of cotinine and a binding substance, and a use therefor
10/18/2012WO2012141285A1 Biomarker for breast cancer
10/18/2012WO2012141201A1 Peptide for cancer immunotherapy and method using same
10/18/2012WO2012141026A1 Fusion protein
10/18/2012WO2012140620A1 Compositions for preventing and/or treating an infection by an hiv-1 virus
10/18/2012WO2012140296A1 Antibody, kit and method for determining amyloid peptides
10/18/2012WO2012140214A1 IMMUNOAFFINITY SEPARATION MATERIALS COMPRISING ANTI-IgE ANTIBODY DERIVATIVES
10/18/2012WO2012106478A3 Methods and devices for immunodiagnostic applications
10/18/2012WO2012092374A3 Express humanization of antibodies
10/18/2012US20120266261 Neurovirulent strain of the west nile virus and uses thereof
10/18/2012US20120266260 Diagnosing and treating iga nephropathy
10/18/2012US20120264921 Human antibodies specifically binding to the hepatitis b virus surface antigen
10/18/2012US20120264919 Interleukin-21 receptor binding proteins
10/18/2012US20120264918 Purification method which prevents denaturation of an antibody
10/18/2012US20120264917 Biparatopic protein constructs directed against il-23
10/18/2012US20120264916 Methods of Preventing and Removing Trisulfide Bonds
10/18/2012US20120264915 Chromatography purification of antibodies
10/18/2012US20120264763 Indoline Anti-Cancer Agents
10/18/2012US20120264625 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/18/2012US20120264149 Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
10/18/2012US20120264147 Diagnostic Marker for Hepatocellular Carcinoma Comprising Anti-FASN Autoantibodies and a Diagnostic Composition for Hepatocellular Carcinoma Comprising Antigens Thereof
10/18/2012US20120264143 Cytokine-like proteins
10/18/2012US20120264139 Method for diagnosing acute coronary syndrome
10/18/2012US20120264123 Extracellular Serine Protease
10/18/2012US20120263858 Isolated plant gdsl lipase
10/18/2012US20120263751 Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Nipah Infections
10/18/2012US20120263744 Compositions And Methods Involving Respiratory Syncytial Virus Subgroup B Strain 9320
10/18/2012US20120263735 Synthetic immunogenic glycoconjugate for melanoma immunotherapy
10/18/2012US20120263734 Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus Infections
10/18/2012US20120263732 Cd40 antibody formulation and methods
10/18/2012US20120263730 Receptors of rspo2 and rspo3
10/18/2012US20120263729 Compositions and methods for treating cardiovascular disease
10/18/2012US20120263726 Pharmaceutical composition and method of inhibiting of production or amplifying of elimination of P24 protein
10/18/2012US20120263724 Escherichia coli o157:h7 proteins and uses thereof
10/18/2012US20120263722 Dual Variable Domain Immunoglobulins and Uses Thereof
10/18/2012US20120263719 Compositions and methods for treating aspergillosis
10/18/2012US20120263718 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
10/18/2012US20120263711 Engineering Fc Antibody Regions to Confer Effector Function
10/18/2012US20120263710 Administering anti-placental growth factor antibodies
10/18/2012US20120263707 Broad Spectrum ErbB Ligand Binding Molecules and Methods for Preparing and Using Them
10/18/2012US20120263702 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis
10/18/2012US20120263654 Melanoma specific biomarker
10/18/2012US20120263647 Pro104 Antibody Compositions and Methods of Use
10/18/2012CA2833147A1 Anti- il-1r1 inhibitors for use in cancer
10/18/2012CA2831258A1 Compositions for preventing and/or treating an infection by an hiv-1 virus
10/18/2012CA2828307A1 Antibody, kit and method for determination of amyloid peptides
10/18/2012CA2827850A1 Polyclonal antibody compositions
10/18/2012CA2820824A1 Adam6 mice
10/17/2012EP2511371A1 Anticancer anti-mortalin peptide antibodies
10/17/2012EP2511368A1 Recombinant measles virus useful as bivalent vaccine against measles and nipah virus infection
10/17/2012EP2511301A2 Human antibodies to ERBB2
10/17/2012EP2511300A2 High affinity human antibodies to human IL-4 receptor
10/17/2012EP2511299A1 Humanized anti-CD70 binding agents and uses thereof
10/17/2012EP2511298A2 Compositions and Methods for Diagnosing and Treating Cancer
10/17/2012EP2511297A1 Anti-CD38 human antibodies and uses therefor
10/17/2012EP2511296A1 Antibody, kit and method for determination of amyloid peptides
10/17/2012EP2511295A1 Compositions for preventing and/or treating an infection by an HIV-1 virus
10/17/2012EP2511291A2 Chlamydia antigens
10/17/2012EP2510948A1 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance
10/17/2012EP2510941A2 Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
10/17/2012EP2510940A1 Use of cyr61 protein for preparing medicine
10/17/2012EP2510013A1 Pcsk9 antagonists
10/17/2012EP2510012A1 Anti-c4.4a antibodies and uses thereof
10/17/2012EP2510011A1 Monoclonal antibodies that bind b7h6 and uses thereof
10/17/2012EP2510010A1 Antibodies binding preferentially human csf1r extracellular domain 4 and their use
10/17/2012EP2510009A1 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof
10/17/2012EP2510008A1 Trispecific therapeutics against acute myeloid leukaemia
10/17/2012EP2510007A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012EP2510006A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012EP2510005A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012EP2510004A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012EP2510003A1 Neutralizing prolactin receptor antibodies and their therapeutic use
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 1494